Results 221 to 230 of about 132,304 (290)

Correlation between 146S Antigen Content in Foot-and-Mouth Disease Inactivated Vaccines and Immunogenicity Level and Vaccine Potency Alternative Test Methods. [PDF]

Vet Sci
Li Y, Yang R, Yin F, Zhang H, Zhai G, Sun S, Tian B, Zeng Q.   +7 more
europepmc   +1 more source

[Inactivated influenza vaccines].

Voprosy virusologii, 1979
O G, Andzhaparidze, T A, Bektemirov
openaire   +1 more source

The Keystone‐Pathogen Hypothesis Updated: The Role of Porphyromonas gingivalis in Periodontitis

Journal of Periodontal Research, EarlyView.
Porphyromonas gingivalis orchestrates a coordinated manipulation of immune and inflammatory responses in periodontal tissues which leads to the generation of a dysbiotic, subgingival biofilm community, and progression of periodontitis. The type 9 secretion system, lipid A modification, and the formation of outer membrane vesicles are important ...
Mike A. Curtis, James A. Garnett, Richard P. Darveau   +2 more
wiley   +1 more source

Dynamic Profiling and Prediction of Antibody Response to SARS-CoV-2 Booster-Inactivated Vaccines by Microsample-Driven Biosensor and Machine Learning. [PDF]

Vaccines (Basel)
Bian S, Shang M, Tao Y, Wang P, Xu Y, Wang Y, Shen Z, Sawan M.   +7 more
europepmc   +1 more source

Vaccination Against Tuberculosis: Revamping BCG by Molecular Genetics Guided by Immunology

, 2020
Kaufmann, S.
core   +1 more source

Vaccination Coverage and Factors Associated With Incomplete Vaccination Schedules in Children Under 5 in a Peripheral Area of the Federal District of Brazil

Public Health Nursing, EarlyView.
ABSTRACT Objective To estimate vaccination coverage (VC) and analyze the factors associated with the incomplete vaccination schedule (IVS) in children under 5 years of age in two Basic Health Units in the Federal District of Brazil. Design A cross‐sectional study.
Ivea Rayane Mendes Nicacio Viana, Henry Maia Peixoto   +1 more
wiley   +1 more source

Safety, immunogenicity and protective effectiveness of heterologous boost with a recombinant COVID-19 vaccine (Sf9 cells) in adult recipients of inactivated vaccines. [PDF]

Signal Transduct Target Ther
Luo W, Gan J, Luo Z, Li S, Wang Z, Wu J, Zhang H, Xian J, Cheng R, Tang X, Liu Y, Yang L, Mou Q, Zhang X, Chen Y, Wang W, Wang Y, Bai L, Wei X, Zhang R, Yang L, Chen Y, Yang L, Li Y, Liu D, Li W, Chen L.   +26 more
europepmc   +1 more source

Immunogenicity and reactogenicity of SARS-CoV-2 mRNA and inactivated vaccines in healthy adolescents

, 2022
Lau Y, Duque JR, Wang X, Leung D, Cheng S, Cohen C, Mu X, Hachim A, Zhang Y, Chan S, Chaothai S, Kwan K, Chan K, Li J, Luk L, Tsang L, Wong W, Cheang C, Hung T, Lam J, Chua G, Tso W, Ip P, Kavian N, Leung W, Valkenburg S, Peiris M, TU W, Mori M.   +28 more
europepmc   +1 more source

Inactivated vaccines reduce the risk of liver function abnormality in NAFLD patients with COVID-19: a multi-center retrospective study. [PDF]

EBioMedicine
Chen Z, Tang W, Feng N, Lv M, Meng F, Wu H, Zhao Y, Xu H, Dai Y, Xue J, Wang J, Xu A, Zhang B, Chu D, Li Y, Wu D, Dong L, Zhang S, Xue R.   +18 more
europepmc   +1 more source

Inactivated influenza vaccines

, 2008
Carolyn B. Bridges, Jacqueline M. Katz, Roland A. Levandowski, Nancy J. Cox   +3 more
openaire   +1 more source